Haemonetics Corporation (HAE) Social Stream
HAEMONETICS CORP (HAE) Price Targets From Analysts
The tables below show price targets and recommendations from analysts covering HAEMONETICS CORP.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2021-11-09 | 8 | $108 | $68 | $81.571 | $82.83 | -1.52% |
| 2021-11-10 | 8 | $108 | $68 | $78.428 | $82.83 | -5.31% |
| 2022-01-06 | 8 | $108 | $59 | $76 | $82.83 | -8.25% |
| 2022-01-07 | 8 | $108 | $59 | $74.857 | $82.83 | -9.63% |
| 2022-02-08 | 7 | $108 | $59 | $74.285 | $82.83 | -10.32% |
| 2022-04-11 | 8 | $80 | $59 | $70 | $82.83 | -15.49% |
| 2022-05-10 | 7 | $80 | $59 | $67.4 | $82.83 | -18.63% |
| 2022-05-11 | 7 | $80 | $59 | $67.8 | $82.83 | -18.15% |
| 2022-07-14 | 5 | $80 | $59 | $72.4 | $82.83 | -12.59% |
| 2022-09-15 | 6 | $90 | $59 | $79.8 | $82.83 | -3.66% |
| 2022-10-05 | 6 | $90 | $74 | $84 | $82.83 | 1.41% |
| 2022-10-11 | 6 | $90 | $80 | $86.2 | $82.83 | 4.07% |
| 2022-10-13 | 7 | $90 | $80 | $86.833 | $82.83 | 4.83% |
| 2022-11-08 | 7 | $105 | $88 | $93.166 | $82.83 | 12.48% |
| 2022-12-12 | 7 | $105 | $90 | $96.833 | $82.83 | 16.91% |
| 2023-01-06 | 7 | $105 | $84 | $95.833 | $82.83 | 15.7% |
| 2023-01-24 | 7 | $110 | $84 | $97.5 | $82.83 | 17.71% |
| 2023-02-07 | 6 | $110 | $84 | $97.5 | $82.83 | 17.71% |
| 2023-02-08 | 6 | $110 | $88 | $100.166 | $82.83 | 20.93% |
| 2023-04-05 | 6 | $115 | $88 | $101 | $82.83 | 21.94% |
| 2023-05-11 | 6 | $115 | $90 | $101.5 | $82.83 | 22.54% |
| 2023-05-12 | 6 | $115 | $90 | $103.166 | $82.83 | 24.55% |
| 2023-05-15 | 6 | $115 | $90 | $105.333 | $82.83 | 27.17% |
| 2023-08-08 | 5 | $115 | $90 | $107.2 | $82.83 | 29.42% |
| 2023-08-09 | 5 | $115 | $90 | $107.8 | $82.83 | 30.15% |
| 2023-10-24 | 5 | $115 | $94 | $108.6 | $82.83 | 31.11% |
| 2023-11-02 | 5 | $115 | $94 | $108.6 | $82.83 | 31.11% |
| 2023-11-20 | 5 | $115 | $94 | $106.8 | $82.83 | 28.94% |
The Trend in the Analyst Price Target
Over the past 27 months, HAE's average price target has gone up $27.55.
Over the past 43 weeks, HAE's average upside potential has been 20.16%.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Share Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2023-04-05 | 6 | 115 | 88 | 100.166 | 84.34 | 18.76% |
| 2023-10-02 | 5 | 115 | 94 | 108.600 | 88.16 | 23.19% |
| 2023-10-24 | 5 | 115 | 94 | 108.600 | 87.83 | 23.65% |
| 2023-11-02 | 5 | 115 | 94 | 108.600 | 85.46 | 27.08% |
| 2023-11-04 | 5 | 115 | 94 | 106.800 | 88.43 | 20.77% |
HAE Broker Recommendations Summary
| Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
|---|---|---|---|---|---|---|
| 1.83 | 3 | 1 | 2 | 0 | 0 | 6 |
The Trend in the Broker Recommendations
Over the past 23 months, HAE's average broker recommendation rating improved by 0.15.
Use the points listed below to better contextualize what this analyst price target and recommendations data data means for investors.
- In the context of all US stocks, HAEMONETICS CORP's variance in analysts' estimates is lower than -1056.74% of them.
- In the context of stocks in the mid market cap category, HAEMONETICS CORP's average analyst price target is higher than 2890.35% of them.
- To contextualize these metrics, consider that out of Healthcare stocks, HAEMONETICS CORP's upside potential (average analyst target price relative to current price) is higher than 709.58% of them.
- HAE has a greater number of analysts covering the stock than 1312.67% of stocks in the mid market cap category.
Stocks similar to HAEMONETICS CORP in the Medical Equipment industry regarding analyst recommendations and price targets are NARI, SKIN, and LUNG.
View All Top Stocks by Price Target
Is HAE a Buy, Hold or Sell? See the POWR Ratings now!